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Abstract 
Given the monotony and extended driving periods inherent in transport truck driving, truck 
drivers might rely on stimulants to sustain attention and combat fatigue.  Research indicates 
stimulants improve some cognitive functions but impair driving ability, and stimulant use is 
common among truck drivers.  In addition, stimulant use is linked to collisions.  Research to date 
on collision culpability among stimulant-positive truck drivers is sparse and presents with 
limitations due to small sample sizes and a lack of control over confounding variables.  The 
present study investigated the influence of stimulants on unsafe driving actions (UDAs) in 
collisions. The odds of being stimulant-positive were expected to be statistically significantly 
higher for drivers who committed at least one UDA that led to a collision.  Using the Fatality 
Analysis Reporting System (FARS) database, the author compared truck drivers who had at least 
one UDA recorded to a control group of drivers who had none.  Logistic regression was used in 
order to account for the influence of confounding variables (age, previous driving record, and 
other drug-use) and to calculate the odds ratio of being stimulant-positive in the event of an 
UDA.  Results indicate that the odds of being stimulant-positive are statistically significantly 
greater for truck drivers who committed an UDA (OR 2.29, 95% CI 1.7-3.0).  In addition, 
Pearson’s Chi-square models indicated stimulant-positive truck drivers were significantly more 
likely to have a history of infractions on their driving record and to have other drugs in their 
system.  The results suggest stimulants negatively influence driving ability and truck drivers 
should not use stimulants while driving.  In addition, the results support the inclusion of previous 
driving record and other drug use data as control variables for future studies.  Despite this, the 
finding that 0.58% of truck drivers in the FARS database tested positive for stimulants suggests 
that stimulant use is not common.    
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The Influence of Stimulants on Transport Driver Culpability in Fatal Collisions 
Failure to obtain adequate sleep is a well-documented problem among transport truck 
drivers (Hanowski, Hickman, Fumero, Olson, & Dingus, 2007; Hanowski, Wierwille, & Dingus, 
2003).  The cognitive deficits associated with sleep loss include impairment in memory, 
vigilance, attention, and psychomotor abilities (Dinges et al., 1997; Oginska & Pokorski, 2006) 
and this influences driving performance (Mills, Spruill, Kanne, Parkman, & Zhang, 2001; Roge, 
Pebayle, Hannachi, & Muzet, 2003; Ting, Hwang, Doong, & Jeng, 2008).  In order to combat 
these detrimental effects, truck drivers report using both licit and illicit stimulants (Davey, 
Richards, & Freeman, 2007; Mabbot & Hartley, 1999).  In addition, stimulant are frequently 
detected among truck drivers killed in work-related collisions (Brodie, Lyndal, & Elias, 2009; 
Drummer et al., 2003) as well as deceased drivers deemed to be at fault in collisions (Crouch et 
al., 1993; Drummer et al., 2004).  Even though stimulants can enhance cognitive functions such 
as vigilance, attention, psychomotor functioning, memory, and visuospatial/visuomotor abilities 
(Camp-Bruno & Herting, 1994; Koelega, 1993; Silber, Croft, Papafotiou, & Stough, 2006), 
research suggests they create driving impairments (Logan, 1996; Logan, Fligner & Haddix, 
1998; Silber, Papafotiou, Croft, & Ogden 2005).  Despite the link between stimulants, collisions, 
and driving deficits, other research suggests stimulants might improve both cognitive 
performance and driving performance when used to combat fatigue (Caldwell, Caldwell, & 
Darlington, 2003; Logan, 2002; Moolenaar, 1999).  
 Given the complexities of the relationship between fatigue, stimulants, and collisions, 
research addressing collision culpability among transport truck drivers is needed.  To ascertain 
the role of stimulants in transport truck driver collisions, research that establishes driver 
culpability and controls for confounding variables is required.  In order to properly understand 
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the rationale for this need, a review of the literature is provided on the following: stimulants and 
classification, sleep patterns of transport truck drivers, the individual and combined effects of 
fatigue and stimulants on cognition and driving, and the relationship between stimulant use and 
culpability in collisions. 
Sleep Loss and Fatigue among Transport Truck Drivers 
 In Canada the Commercial Vehicle Drivers Hours of Service Regulations controls the 
amount of driving and rest time required for transport truck drivers (Government of Canada, 
2008).  Similarly, the United States government recognized fatigue as an issue among transport 
truck drivers and implemented revised hours-of-service (HOS) regulations in order to increase 
sleep and rest time among drivers (Hanowski et al., 2003).  Prior to the new guidelines Mitler, 
Miller, Lipsitz, Walsh, and Wylie (1997) found that drivers spent an average of 5.18 hours in bed 
per 24 hour day and averaged 4.78 hours of electrophysiologically verified sleep per day.  
Hanowski et al. (2003) found drivers who were deemed at fault in critical incidents received 
significantly less sleep (5.33 hours on average) in the 24 hours prior to the incident than drivers 
who were not at fault in critical incidents (6.08 hours on average).  After the implementation of 
the revised HOS regulations in the United States, Hanowski et al. (2007) conducted a similar 
study.  Similar to Hanowski et al. in 2003, data for this sample of truck drivers (N = 82) was 
collected with video recording equipment and sensors inside and outside of the truck for 16 
weeks.  Sleep data were also collected for 7 days with a sensor worn by participants.  The 
average amount of sleep per night for all drivers was 6.28 (SD = 1.42) hours suggesting the 
possibility that sleep has increased among truck drivers since the revised HOS regulations came 
into effect.  Matched-paired t-tests revealed that drivers who were deemed to be at fault in a 
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critical incident averaged 1.45 hours less sleep in the 24 hours prior to the incident (M = 5.25, SD 
= 2.15) compared to the overall average for at fault drivers (M = 6.70, SD = 1.65). 
 Although drivers might be getting more hours of sleep per night due to regulations, it still 
may not be enough.  Research indicates that the optimal amount of sleep for adults is between 
seven and eight uninterrupted hours per night and this needs to be routine (Lee-Chiong, 2006).  
Although research suggests sleep has increased since the revised HOS regulations, drivers still 
might not be obtaining optimal amounts of sleep (for example, see Hanowski et al., 2007).  
Friswell and Williamson (2008) found that 89.4% of truck drivers reported fatigue (impaired 
driving, slowed reactions, decreased traffic awareness and attention to signs, and poorer steering) 
with 38.1% describing fatigue at least once per week.  Insufficient sleep was identified as a 
contributing factor by 86.9% of the sample.  In addition, 44.8% of this sample reported falling 
asleep at the wheel during the last year of work-related driving.  Even if truck drivers did obtain 
optimal amounts of sleep they still face other fatigue inducing factors inherent in their work such 
as extended periods of driving and monotonous driving.  For the Friswell and Williamson (2008) 
sample, long driving hours and monotonous driving conditions were identified as contributors to 
fatigue by 86.2% and 85.6% of drivers, respectively.    
 Monotonous driving conditions and extended driving periods. Highways and straight 
roadways with monotonous scenery are considered monotonous driving environments (Horne & 
Reyner, 1995; Ting et al., 2008).  Research indicates highway driving creates fatigue and 
contributes to collisions, but stimulating scenery can alleviate this effect (Thiffault & Bergeron, 
2003).  In addition, switching from a complex to a monotonous road environment can reduce 
alertness and increase weariness and fatigue (Liu & Wu, 2009).  Monotonous driving also 
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reduces vigilance and drivers are not adept at accurately identifying this decrement in ability 
(Schmidt et al., 2009).   
Research shows that extended periods of driving can negatively influence driving ability 
(Nilsson, Nelson, & Carlson, 1997; Philip, Taillard, Quera-Salva, Bioulac, & Akerstedt, 1999; 
Ranney, Simons, & Masalonis, 1999) and this is exacerbated by monotonous driving conditions 
(Liu and Wu, 2009; Roge, et al., 2003).  For example, a study by Ting, Hwang, Doong and Jeng 
(2008) suggests 90 minutes of driving is enough to create significant fatigue.  Participants’ 
subjective sleepiness ratings on a Likert scale increased significantly over 90 minutes from pre-
test (Mdn = 2.37) to post-test (Mdn = 4.33).  One-way repeated ANOVA with sequential ten 
minute periods revealed that reaction times significantly increased over 90 minutes.  Reaction 
time increased 0.31 seconds from ten to 90 minutes of driving and this increase resulted in an 
additional eight meters of stopping distance while travelling at 100 kilometers per hour.  Lastly, 
an overall performance index was calculated by combining data on car speed, headway, lateral 
position, and frequency of edge-line crossings.  A repeated ANOVA indicated statistically 
significant decreases in overall performance over time.  Other research indicates 60 minutes of 
driving creates fatigue and impairs performance (Liu & Wu, 2009).  Specifically, Liu and Wu 
found drivers’ feelings of fatigue on the psychological fatigue questionnaire (using a three point 
Likert-type scale) increased significantly from 30 to 60 minutes of driving in a monotonous 
driving environment (from approximately 1.4 to 2.5) and a complex driving environment (from 
approximately 1.5 to 2.7).  Roge et al. (2003) found 30 minutes of monotonous driving was 
enough to impede driving performance as indicated by movement within the lane (lateral 
instability) and difficulty keeping distance from the lead vehicle (longitudinal instability).  
Although statistical significance was not attained, lateral and longitudinal instability were 
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negatively influenced by driving duration.  Lateral instability during the second half hour (M = 
0.32, SD = 0.12) was worse than in the first half-hour (M = 0.29, SD = 0.12).  Longitudinal 
instability was also worse in the second half-hour (M = 7.299, SD = 5.60) than the first half-hour 
(M = 6.097, SD = 3.09).  In addition, the results indicated the negative influence of driving 
duration on drivers’ ability to locate peripheral stimuli was statistically significant.  That is, 
during the first half-hour drivers successfully detected an average of 57.8% (SD = 21.2) of the 
peripheral stimuli compared to 47% (SD = 24.2) in the second half-hour. 
It is well documented that fatigue has detrimental effects on driving performance (Mills 
et al., 2001; Roge et al., 2003; Ting et al., 2008) and truck drivers report fatigue as an issue 
(Friswell & Williamson, 2008).  In addition, fatigue increases the chances a collision will be fatal 
(Bunn, Slavova, Struttmann, & Browning, 2005).  Morrow and Crum (2004) suggest a myriad of 
factors inherent in transport driving that contribute to fatigue: work overload, schedule 
irregularity, sleep pattern disturbances, and insufficient recovery time between shifts.  Taken 
together, the sleep patterns and work requirements of transport truck drivers is concerning when 
considering the negative influence these factors have on driving performance.  It seems plausible 
that transport drivers are aware of these effects and search for means of overcoming fatigue.  
One way some truck drivers attempt to overcome the influence of fatigue is through use of licit 
and illicit stimulants (Brodie et al., 2009; Davey et al., 2007; Drummer et al., 2003; Mabbot & 
Hartley, 1999).    
Stimulants and Classification 
 Although stimulants can be divided into four broad groups (behavioural or central 
nervous system [CNS] stimulants, clinical antidepressants, convulsants, and caffeine/nicotine) 
(Julien, 2005), only behavioural stimulants are directly relevant to the current study.  
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Specifically, only the behavioural class of stimulants are included in the FARS database, and the 
physiological effects of behavioural stimulants are most directly related to driving ability.  By 
mimicking and/or augmenting the action of norepinephrine (as well as augmenting dopamine and 
serotonin), behavioural stimulants influence the CNS.  This causes excitation of CNS functions, 
thereby increasing physiological activity (Julien, 2005).  When considering sleep deprivation and 
vigilance performance, psychomotor stimulants are of interest given some of their effects: 
increased behavioural and motor activity, increased alertness, increased concentration, and 
wakefulness (Pleuvry, 2009).  In addition to these effects, behavioural stimulants shift blood 
flow from skin and organs to muscles, increase body temperature, increase blood pressure and 
heart rate, and increase oxygen and glucose levels in the blood stream.  This influence is similar 
to the fight or flight response, or our natural response to emergency situations (Julien, 2005).  
Illicit stimulants such as cocaine and methamphetamine, as well as large doses of licit stimulants 
can produce excitement and euphoria.  Behavioural stimulants can be further subdivided into 
amphetamines, nonamphetamines, and cocaine and its derivatives (Julien, 2005). 
 Amphetamines. The amphetamines mimic and potentiate norepinephrine, and are 
structurally similar to this neurotransmitter.  Although amphetamine and its derivatives (for 
example, dextroamphetamine and methamphetamine) vary in potency, they carry similar effects 
(Julien, 2005).  Pharmacological effects of the amphetamines vary with dose.  Even at low doses 
(for example, less than five milligrams of amphetamine, or 2.5 to 20 milligrams of 
dexamphetamine), increased alertness and excitement are observed.  Even though this briefly 
provides a high boost of energy, dexterity and fine motor skills are impaired (Julien, 2005).  At 
moderate doses (for example, five to 50 milligrams of amphetamine), respiration is stimulated, 
motor activity is increased, wakefulness is promoted, and appetite is suppressed.  However, 
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restlessness, tremors, and agitation can be observed (Julien, 2005).  Concerning wakefulness, 
there is a rebound fatigue phase after drug use is discontinued, and full recovery to normal sleep 
pattern can take weeks.  At high doses (for example, 100 milligrams of amphetamine) and with 
chronic use, paranoia and mania can occur due to excessive levels of norepinephrine (Julien, 
2005).  In addition, fine motor skills and dexterity are further impaired.          
In addition to clinical uses, amphetamines (especially methamphetamine) are often used 
illicitly because they can produce euphoria and because of their ability to improve psychomotor, 
intellectual, and athletic performance (Julien, 2005).  The primary medical use for the 
amphetamines is for treating narcolepsy as well as some attention deficit/hyperkinetic disorders 
in children.  To a lesser extent, amphetamines can also be used to treat petit mal epilepsy.  
Amphetamines also carry anorexic effects but are controversial in the treatment of obesity due to 
high abuse potential and rapid tolerance development (Julien, 2005; Pleuvry, 2009).   
 Nonamphetamines.  Other behavioural stimulants such as ephedrine, methylphenidate, 
sibutramine, and modafinil are structurally very similar to amphetamines but lack the basic 
amphetamine nucleus (Julien, 2005).  Although the effects of these stimulants are relatively mild 
compared to the amphetamines, physiological and behavioural patterns are similar, as these 
drugs also influence synaptic activity of norepinephrine (Julien, 2005).  In addition, these drugs 
differ from one another in intensity of their physiological and behavioural effects.  Despite the 
similarity to the amphetamine class, nonamphetamines might not influence the CNS as strongly 
as amphetamines. Ephedrine is used as a nasal decongestant and to treat hypotension during 
surgery (Julien, 2005; Pleuvry, 2009).  Ephedrine is also detected in the majority of illicit 
amphetamine concoctions (Julien, 2005).  Due to anorexic effects, sibutramine can be used for 
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weight loss.  Lastly, some nonamphetamines (such as methylphenidate and modafinil) are used 
to treat attention deficit hyperactivity disorder (ADHD). 
 Cocaine and benzoylecgonine.  Cocaine blocks the presynaptic reuptake of 
norepinephrine, thereby increasing the synaptic activity of this neurotransmitter (Julien, 2005).   
The effects of cocaine are similar to amphetamine, and extremely similar to methamphetamine.  
Despite this similarity, an average intranasal dose of cocaine (20 to 50 milligrams) is 
metabolized in five to 15 minutes, whereas a similar dose of amphetamine might last several 
hours.  However, benzoylecgonine is the primary metabolite of cocaine and can carry mild CNS 
stimulation for several hours after cocaine use is terminated (Bloom & Kupfer, 1995).  As with 
cocaine, benzoylecgonine carries similar effects as the amphetamines (Julien, 2005; Pleuvry, 
2009), mostly because they produce similar norepinephrine synaptic actions.  Cocaine is known 
for producing excitement and euphoria, as well as increasing mental awareness and ability.  
Although cocaine and its derivatives increase motor activity, coordination decreases as the dose 
increases (Julien, 2005).  Even at low doses, cocaine can lead to undesirable reactions (increased 
blood pressure and heart rate, paranoia, sweating, anxiety) (Julien, 2005). Due to a high potential 
for abuse and dependency, cocaine is not recognized as clinically useful despite its strong local 
anaesthetic potential.  
The Influence of Stimulants on Cognition and Driving.  
 The use of stimulants by transport truck drivers to combat fatigue is concerning when 
considering the link to fatal collisions (e.g., Brodie et al., 2009; Crouch et al., 1993).  However, 
the exact nature of the relationship between stimulants and collisions is not clear.  Despite being 
linked to collisions, stimulants can cause improvements in driving-related cognitive functions 
(e.g., attention, psychomotor functioning, memory, visuospatial and visuomotor abilities) 
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(Camp-Bruno & Herting, 1994; Elliott et al., 1997; Koelega, 1993; Rogers et al., 1999; Silber, 
Croft, Papafotiou, & Stough, 2006).  For example, reaction times (in milliseconds) on the 
Inspection Time Task for drivers on d-amphetamine (M = 384.5, SD = 6.0) as well as 
methamphetamine (M = 379.4, SD = 8.7) were statistically significantly lower than the reaction 
time of drives given a placebo (M = 396.8, SD = 7.8; M = 395.0, SD = 8.8, respectively) (Silber 
et al., 2006).  Methylphenidate also speeds reaction time.  Using a computer generated stimulus 
identification task, Naylor, Halliday, and Callaway (1985) found statistically significant 
decreases in reaction time; low and high doses of methylphenidate decreased reaction time by 37 
and 32 milliseconds, respectively.    
 Research indicates stimulants cause improvements in vigilance performance (Camp-
Bruno & Herting, 1994; Rogers et al., 1999).  Vigilance tasks (also known as monitoring tasks) 
require sustained attention in an attempt to identify randomly occurring unusual events.  For 
example, Camp-Bruno and Herting (1994) used a computer generated reaction time task and 
found methylphenidate reduced reaction time by approximately 30 milliseconds after 25 minutes 
and 40 milliseconds after 4 hours.  In addition to improving performance under normal vigilance 
conditions, stimulant use can return vigilance performance to baseline in fatigued participants 
even after lengthy periods of wakefulness (e.g., 22 to 85 hours without sleep) (Killgore et al., 
2008; Ramsey et al., 2008; Wesensten, Killgore, & Balkin, 2005).  For example, Killgore et al. 
(2008) compared dextroamphetamine users to a placebo control group and found that after 44 
hours of wakefulness, reaction time remained at baseline for the treatment group but increased 
approximately 300% for the control group.  In addition, speed improved slightly for the 
treatment group but dropped to less than 60% of baseline for the control group. 
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Some research suggests stimulants not only mitigate vigilance performance decrements 
by returning performance to baseline in fatigued participants, but also improve performance with 
time.  For example, Moolenaar et al. (1999) compared ephedrine users to a placebo group and 
uncovered attentional and performance improvements over four hours using a divided attention 
task.  Participants tracked a computer generated stimulus with a cursor. The time off-target 
decreased across the four hour period for the treatment group from approximately 26 seconds to 
22.5.  For the placebo group, this time increased from approximately 22 to 34 seconds.  
Participants simultaneously identified a peripheral signal.  For this task, ephedrine users made 
statistically significantly fewer errors than the placebo group.  A meta-analysis by Koelega 
(1993) reviewing the effects of amphetamine and methylphenidate on vigilance revealed 
improvements in reaction time and accuracy and this effect was not restricted to a return to 
baseline effect in fatigued participants.  In addition, results of this meta-analysis show the usual 
decrement in vigilance with time is mitigated by stimulant use.   
The above studies show improvements in cognition and vigilance performance with 
stimulant use.  These findings relate to the influence of stimulants after a period of time has 
passed since ingestion (often based on half-life) in a controlled environment.  However, research 
indicates that driving deficits are especially evident during the acute and withdrawal/rebound 
fatigue phase (Logan, 1996; Logan, 2002). Concerning long-term stimulant use, the majority of 
research shows cognitive deficits.  For example, deficits in attention abilities as well as visual 
and working memory are evident in long-term cocaine users (Jovanovski, Erb, & Zakzanis, 
2005).  In 2002, Simon et al. investigated the cognitive performance of long-term 
methamphetamine and cocaine abusers, and both demonstrated impairments in memory, 
attention, and in the ability to ignore irrelevant information.     
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 Aside from chronic stimulant use and the acute and withdrawal phases, research 
generally shows cognitive improvements with moderate amounts of stimulants.  However, the 
exact nature of the relationship between these cognitive functions and actual driving is not clear.  
In addition, the use of stimulants in a controlled environment at low doses might not be 
applicable to real-world situations.  Research also fails to address the different phases of 
stimulant intoxication and does not investigate large doses and/or “binges”.  In addition, there is 
an absence of in situ research.  Although there is not a large body of research assessing the 
influence of stimulants on actual driving, a limited amount of research approaches this using 
simulated driving. Some studies demonstrate driving deficits such as swerving, speeding, erratic 
driving, and risk taking with stimulant use (Logan, 1996; Logan, Fligner, & Haddix, 1998; Silber 
et al., 2005).     
 Silber et al. (2005) used a driving simulator to examine the effects of amphetamines on 
driving performance on a freeway and in city traffic under both day and night conditions.  
Drivers received an impairment score based on the occurrence of 34 deleterious driving actions 
(e.g., collisions, improper signalling, dangerous action, wandering, speeding, decreased reaction 
time).  In the treatment group 19 out of 20 participants were ranked as impaired, compared to 13 
out of 20 of the placebo group.  During day driving participants demonstrated decreased 
signalling adherence at intersections, when entering a freeway, and when changing lanes.  
Drivers also failed to stop at red lights more frequently and travelled at lower speeds on the 
freeway when emergency situations occurred.  Aside from a night-time decrease in reaction time, 
drug-administered drivers demonstrated a reduction in driving performance for day-time 
conditions only.  The authors pointed to perceptual narrowing or “tunnel vision” to explain the 
daytime driving deficits without concurrent night time deficits.   Specifically, the sympathetic 
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arousal caused by dexamphetamine can create greater acuity where attention is focused with a 
loss of peripheral acuity.  Therefore information falling outside a driver’s focus could be lost 
thereby impairing driving performance.  The authors suggested that this tunnel-vision effect is 
more important during the day because of the greater amount of relevant information and the 
need for drivers to selectively attend to stimuli.   
 The presence of stimulant-induced tunnel vision is supported by Mills et al. (2001). In 
this study researchers used a single-target and divided attention task across the visual field. 
Dextroamphetamine caused improvements in divided-attention and reaction time for stimuli at 
the center of the display.  However, for stimuli at the outer limits of the monitors, deficits existed 
and increased with distance from the center of the screen.  Therefore stimulant-induced arousal 
improved selective attention for the focal area but limited this ability for the periphery.  The 
authors noted that the scanning of peripheral hazards required while driving creates a risk for 
drivers using stimulants due to a stimulant-induced tunnel-vision effect.  Other research suggests 
that tunnel-vision occurs with extended driving periods and fatigue (Roge et al., 2003).  In the 
Mills et al. (2001) study, stimulants did not return performance to baseline in fatigued 
participants.  In addition, fatigue prevented the stimulant-induced enhancement in divided 
attention as seen in participants who were not experiencing fatigue.            
Stimulant Use and Culpability in Collisions 
 Some research demonstrates stimulant use among commercial truck drivers involved in 
collisions.  For example, using an Australian sample, Brodie et al. (2009) found almost ten 
percent of (six out of 61) heavy vehicle drivers killed in a collision tested positive for stimulants.  
Stimulants detected included amphetamine, methamphetamine, methylene-
dioxymethamphetamine (MDMA), pseudoephedrine, and phentermine.  In another Australian 
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study, Drummer et al. (2003) found even more stimulant users among a sample of 139 deceased 
truck drivers involved in fatal collisions.  From this sample 32 truck drivers (23%) tested positive 
for stimulants (methamphetamine, MDMA, and various types of ephedrine).  In 2004, Drummer 
et al. found 15.8% of a sample of Australian transport truck drivers tested positive for stimulants.  
In support of studies showing stimulant use among transport truck drivers, Crouch et al. (1993) 
found 22% of their sample (168) of United States truck drivers tested positive for stimulants; 8% 
cocaine or benzoylecgonine, 7% amphetamine or methamphetamine, and 7% 
phenylpropanolamine, ephedrine, or pseudoephedrine.  Different results were attained by Longo 
et al. (2000a), in which case 1.8% of their Australian sample tested positive (1 out of 55 truck 
drivers).  However, this study differed from the aforementioned culpability studies; Longo et al. 
investigated stimulant use among non-fatally injured drivers, whereas the above studies 
investigated stimulant use among fatally injured drivers.     
 In addition to the majority of studies finding high percentages of stimulant users among 
deceased collision victims, two self-report studies also reveal stimulant use with Australian truck 
drivers.  Mabbott and Hartley (1999) conducted such a study and found 27.5% (65 out of 236) of 
truck drivers used stimulants as a fatigue countermeasure at an undisclosed time during their 
driving career.  Of these drivers 16 reported using over-the-counter stimulants (caffeine pills, 
herbal drugs, pseudoephedrine), 28 used either prescription or illicit stimulants, and 21 used both 
prescription and illicit stimulants.  Amphetamines were the most common stimulant reported 
followed by prescription appetite suppressants.  Drivers were also asked about peers who use 
stimulants as a fatigue countermeasure, and 28.6% reported knowing one or more peers who 
used stimulants.  In addition, 65.9% of those drivers stated that stimulants were used by their 
peer(s) on at least half of all transport trips.  Davey, Richards, and Freeman (2007) found even 
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higher rates.  In this study 32 out of 35 truck drivers reported previous and/or current stimulant 
use (on any occasion).  Amphetamine was the most common (20 past users and 9 current users), 
followed by pharmaceutical stimulants such as ephedrine or duromine (9 past users and 3 current 
users), and cocaine (3 past users and 3 current users).  
 Although high percentages of stimulant use are detected in deceased collision victims and 
transport truck drivers report using stimulants to combat fatigue, this does not imply a causal 
relationship between stimulant use and collisions.  Other research attempts to implicate 
stimulants by including information on culpability, however, research on culpability among 
stimulant positive truck drivers is limited; at the time of the present study, only one such study 
was found.  In 2004 Drummer et al. found stimulants present in 15.8% (n = 22) of a sample of 
deceased truck drivers who were deemed at fault in the collision.  Culpability was determined 
using a method called responsibility analysis (see Robertson & Drummer, 1994).  This method 
determines culpability by considering eight factors: condition of the road, condition of the 
vehicle, driving conditions, type of crash, witnesses’ observations, road law obedience, difficulty 
of task, and level of fatigue.  The odds ratio (OR) of stimulants being present among collision 
culpable truck drivers was significant, OR 8.83, 95% CI 1.00–78.     
 The above study by Drummer et al. (2004) suggests collision culpability among fatally 
injured stimulant-positive transport drivers.  However, this study presents with several 
limitations.  In this study, stimulants had the strongest measured association with culpability.  
However, the CI (1.0-77.8) is wide and the inclusion of one in the CI represents marginal 
statistical significance.  The sample size for this study also presents a major limitation: only 22 
transportation truck drivers could be included after controlling for confounding variables such as 
alcohol.  Sample size is an issue in other culpability research as well.  Longo et al. (2000b) 
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investigated culpability among drivers testing positive for stimulants compared to those who 
tested negative.  However, the sample for this study only included 55 truck drivers.  Since this 
study calculated culpability among all motor vehicle drivers, the small number of truck drivers 
and the unique collision and drug-use patterns among this population prompted the researchers to 
remove truck drivers from the analysis.   
In addition to small sample sizes, the above culpability studies do not control for driving-
related risk taking behaviour and/or poor driving abilities.  Specifically, drivers might be at an 
increased risk for collision culpability due to a general tendency to take risks while driving or 
simply because they are not good drivers.  These factors might be reflected by higher instances 
of driving infractions on their driving record.  Drivers’ previous driving records were not 
controlled for thereby introducing unsafe driving tendencies as a potential confounder.  Also, all 
of the drivers in these studies were killed as a result of the collision.  Stimulant detection is 
higher among truck drivers who were killed in a collision (Brodie et al., 2009; Crouch et al., 
1993; Drummer et al., 2003, Drummer et al., 2004) than those who were not (Longo et al., 
2000a).  Although this does not invalidate the results, culpability among stimulant positive at-
fault transport truck drivers who were not killed during the collision could yield different results.   
 Another limitation in the available culpability research concerns the absence of 
information on specific driving actions related to culpability.  That is, information on driving 
actions committed by stimulant users that lead to culpability could be useful towards 
understanding the influence of stimulants on specific driving actions.   
 Purpose of the Present Study 
Little research exists on the rates of stimulant use among North American transport truck 
drivers.  In addition, existing research uses samples of deceased drivers which bias the results by 
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inflating the findings.  As a first goal, the percentage of truck drivers testing positive for 
stimulants will be presented both overall (from 1993 through 2008) and year-by-year.  The 
second, and primary goal of the present study was to assess whether stimulant use increases the 
odds of performing unsafe driving actions (UDAs: a proxy measure for culpability) while 
improving on previous research by using a large sample, controlling for confounding variables, 
and including drivers who were or were not killed in the collision.   Information on specific 
driving actions performed by stimulant positive drivers is also needed.  Towards this end, UDAs 
committed by truck drivers in the present study were used as a proxy measure for determining 
culpability or crash responsibility.  By using UDAs, the author was able to consider specific 
types of driver actions.  It is hypothesized that drivers who commit an UDA will be at increased 
odds of being stimulant-positive.    
Methods 
Data Source 
 All analyses for the present study were calculated using the Fatality Analysis Reporting 
System (FARS) database.  Since 1975 the National Center for Statistics and Analysis of the 
National Highway Traffic Safety Administration in the United States compiled information on 
fatal traffic collisions for 50 states, Puerto Rico, and the District of Columbia.  For inclusion in 
the FARS data base the crash must have occurred on a traffic way that is normally open to the 
public and the collision must have resulted in a death within 30 days.  In addition, single vehicle 
crashes are not included in the FARS database.  Trained FARS analysts gather, translate, and 
transmit the following data into standard FARS forms: police collision reports, state vehicle 
registration files, state driver licensing files, state highway department data, vital statistics, death 
certificates, coroner/medical examiner reports, hospital medical reports, and emergency medical 
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service reports.  After FARS analysts enter a FARS form into the database an extensive quality 
control program ensures the entry is accurate.  To ensure accuracy, the FARS forms are checked 
online for consistency, range, timeliness, completeness, and accuracy (FARS; National Center 
for Statistics and Analysis, 2006). 
 The FARS database includes three coded data forms: the accident form, the 
vehicle/driver forms, and the person form.  The accident form contains crash information 
pertaining to time, location, the number of people and vehicles involved, weather, and several 
other variables.  The vehicle and driver forms contain information on each vehicle and driver 
involved in the crash (for example, vehicle type, role in the crash, impact points, harmful events, 
driver’s record and license status).  Lastly, the person form contains specific data on people 
involved in the crash: demographic information, role in the crash, drugs and alcohol 
involvement, injury severity, et cetera (FARS; National Center for Statistics and Analysis, 
2006). 
Sample  
 The sample for the present study included FARS cases from 1993 until 2008 because 
specific drug types have been recorded in the FARS database since 1993.  For inclusion in the 
final (restricted) sample drivers had to be male, 20 years of age and over, driving a truck tractor 
(cab only or with any number of trailing units; any weight), blood tested for drugs and alcohol,  
and alcohol free at the time of the collision (blood alcohol concentration of zero).  Those 
excluded were driving a truck other than a truck tractor (semi-truck), were female or unknown 
sex, and/or tested positive for alcohol. 
Cases in the FARS database that involved truck drivers (vehicle type listed in the FARS 
database as a truck weighing at least 10,000 pounds) involved in a fatal collision who were 20 
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years old and over and were blood tested for drugs and alcohol (N = 73,178) were subjected to 
exclusion criteria (see Figure 1).  The sample was reduced by retaining only truck-tractor drivers 
(cab only, or with any number of trailing units; any weight), thereby leaving 52,282 cases; those 
who were driving any other type of truck were excluded.  Female drivers (n = 1,226) and cases 
of unknown sex (n = 3) were then excluded which reduced the sample to 51,056 male drivers.  
Females were removed from the sample because only 3 stimulant-positive female cases were in 
the database; this did not provide sufficient power for statistical analysis and simultaneous 
control over sex differences.  Previous studies demonstrate statistically significant differences 
between male and female drivers concerning the influence of drugs on driving (Dubois, Bedard, 
& Weaver, 2010) as well as the odds of committing an UDA (Dubois, Bedard, & Weaver, 2008).  
With 51,096 male drivers remaining, cases testing positive for any amount of alcohol were 
removed.  After applying all the above exclusionary criteria, a restricted sample of 17,112 
remained.  This restricted sample included 16,982 stimulant-negative drivers and 220 stimulant-
positive drivers. 
Design  
 
 Drivers were classified as stimulant-positive or stimulant-negative.  Cases were drivers 
who had at least one UDA recorded whereas controls had none.  Those drivers who had no 
UDAs recorded were considered not to have contributed to the initiation of the collision.  UDAs 
were used as a proxy measure of crash responsibility.  FARS analysts use police collision reports 
to code up to three (four since 1997) UDAs that were considered to contribute to initiation of the 
collision (Blower, 1998).  Blower (1998) suggests that UDAs are stronger than traffic violations 
at indicating crash culpability as not all contributing factors are chargeable offences.  In addition, 
police officers are less likely to press charges for a traffic violation due to insufficient evidence.  
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By using UDAs, crash investigators’ judgment is considered which provides a more complete 
picture of factors that contributed to the collision (Blower, 1998).  Other studies demonstrate the 
usefulness of UDAs in assessing crash responsibility with the FARS database (Bedard, Dubois, 
& Weaver, 2007; Bedard & Meyers, 2004; Dubois, Bedard, & Weaver, 2010; Dubois, Bedard, & 
Weaver, 2008) and with other crash data (Silber et al., 2005).   
Control variables. The FARS database allowed for control over age, other drugs, and 
past driving record.  Previous research with the FARS database demonstrates age related 
differences pertaining to odds of committing an UDA (Dubois, Bedard, & Weaver, 2008; 
Dubois, Bedard, & Weaver, 2010).  The influence of other drugs was accounted for in order to 
isolate the effects of stimulants on driving.  For the drug test results only blood analysis or blood 
and urine analyses combined were relied upon as urine tests alone might not be accurate enough 
(Bendtsen, Hultberg, Carlsson, & Jones, 1999).  The four stimulant types detected 
(amphetamine, methamphetamine, cocaine, and benzoylecgonine) were grouped together as they 
were all similar in classification: all four stimulants detected were illicit drugs with a half-life 
between approximately 3.8 and 12 hours (Cruickshank & Dyer, 2009; Scheidweiler et al., 2010).  
As previously discussed, alcohol was removed from the analysis entirely due to the 
overwhelming influence of alcohol on driving (e.g., Arnedt et al., 2001; Burian, Liquori, & 
Robinson, 2002).  Past driving record infractions were included in order to control for high-risk 
driving as a potential confounding variables.  The FARS database provides driving records for 
the previous 3 years and includes information on previous collisions, impaired driving offences, 
speeding convictions, other driving related convictions, and license suspension/revocation 
(Dubois, Bedard, & Weaver, 2010).   Drivers younger than 20 years of age were excluded from 
the sample as they would not have sufficient time to develop a driving history. 
THE INFLUENCE OF STIMULANTS ON TRUCK DRIVER 20                                                          
 
 
 
 Analysis. Analyses were conducted using both the entire sample (N = 73,178) as well as 
the restricted sample that remained after applying the exclusionary criteria (n = 17,112).  The 
only analyses conducted for the entire sample of truck drivers (N = 73,178) involved descriptive 
statistics to calculate the rate of stimulant use overall (from 1993 through 2008) as well as a year 
by year analysis.  For the restricted sample (n = 17,112) several analyses were conducted.  An 
independent samples t-test was conducted to compare the age of stimulant-positive and 
stimulant-negative truck drivers.  Pearson’s Chi-square analyses were used as a screening test, 
and to provide population information for any UDA as well as the top five UDAs.  To examine 
differences between stimulant-positive and stimulant-negative drivers in previous driving 
infractions (previous collisions, DWI convictions, other convictions, speeding, and suspensions), 
as well as the use of other drugs (narcotics, depressants, cannabinoids, and “other drugs”), and to 
validate previous driving record and other drugs as confounding variables, Pearson’s Chi-square 
models were used.      
 For the main analysis, only the restricted sample was used (n = 17,112).  Logistic 
regression was used in order to account for the influence of confounding variables (age, previous 
driving record and other drug-use) and to calculate predicted odds and odds ratios of being 
stimulant-positive in the event of an UDA.  Firstly, an unadjusted odds ratio was calculated to 
examine differences in any UDA between stimulant-positive and stimulant-negative drivers 
without controlling for any other variables.  The second model included age and the age squared 
term.  The quadratic age term was used to account for the possibility of a curvilinear relationship 
between age and UDAs (driving performance might be worse for both the youngest and the 
oldest drivers).  For the third model, other drugs were included in the analysis to control for the 
influence of narcotics, depressants, cannabinoids, and “other drugs” on driving performance.  For 
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the fourth and final model, previous driving record infractions (previous collisions, DWI 
convictions, other convictions, speeding, and suspensions) were also included in order to account 
for poor driving skills or risky driving tendencies.  At each step, interactions were examined and 
any significant interactions from previous models were included in the final model.  Using this 
final model, logistic regression models were calculated for the top five individual UDAs (making 
an improper turn, failure to keep in proper lane, operating vehicle in an erratic or reckless 
manner, driving too fast for conditions, and failure to yield right of way or obey traffic signs).  
These models included the aforementioned control variables (age, other drugs, and driving 
record) as well as any interactions that were used in the final model which predicted any UDA.  
Results 
 Descriptive statistics revealed that 0.58% (n = 429) of the entire sample (N = 73,178) 
tested positive for stimulants.  For the year by year analysis, the percentage of drivers from the 
entire sample testing positive for stimulants appeared to increase, particularly after 1999 (see 
Figure 2).  However, the rates of stimulant use are still at or below one percent from 1993 
through 2008.  After applying exclusion criteria, stimulant-positive truck drivers (n = 220) 
represented 0.12% of the restricted sample (n = 17,112).  For the restricted sample, 150 cases 
tested positive for one stimulant, 69 cases tested positive for two stimulants, and one case tested 
positive for three stimulants.  Stimulants detected included amphetemines (n = 78), 
benzoylecgonine (n = 47), cocaine (n = 52), and methamphetamine (n = 115).  For those cases 
that tested positive for one stimulant (n = 150), 19 tested positive for amphetamines, 34 for 
benzoylecgonine, 39 for cocaine, and 57 for methamphetamine. Although age differences 
between stimulant-positive (M = 41.78, SD = 9.07) and stimulant-negative (M = 43.47, SD = 
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11.57) drivers were small, the independent samples t-test revealed a significant difference, 
indicating that stimulant-positive drivers tended to be younger, t(17,110) = 2.1, p = .03.     
 Concerning drugs other than stimulants (narcotics, depressants, cannabinoids, and other 
drugs), a Person’s Chi-Square tests of independent samples revealed significant differences 
between stimulant-positive (n = 220) and stimulant-negative (n = 16,892) drivers (see Table 1).  
Stimulant-positive drivers were significantly more likely to also test positive for narcotics, 
depressants, cannabinoids, and other drugs.  A Person’s Chi-Square tests of independent samples 
revealed statistically significant differences in previous driving record infractions (previous 
collisions, DWI convictions, other convictions, speeding, and suspensions) between stimulant-
positive (n = 220) and stimulant-negative (n = 16,892) drivers (see Table 1).  Compared to 
stimulant-negative drivers, a significantly greater proportion of stimulant-positive drivers had 
previously recorded collisions, DWI convictions, other convictions, speeding infractions, and 
previous license suspensions.  A Pearson’s Chi-Square tests of independent samples revealed 
significant differences between stimulant-positive (n = 220) and stimulant-negative (n = 16,892) 
drivers for any UDA, as well as four of the top five most common UDAs (making an improper 
turn, failure to keep in proper lane, operating vehicle in an erratic or reckless manner, driving too 
fast for conditions); failure to yield right of way or obey traffic signs was not significant (see 
Table 2).   
Main Analysis 
 An unadjusted odds ratio for being stimulant-positive in the event of performing an UDA 
was first calculated without accounting for any other factors.  Results showed that the odds of 
being stimulant-positive were higher for drivers who committed an UDA than for those who did 
not, OR 2.52, 95% CI 1.9-3.3.  To calculate the adjusted odds ratio, contributing factors were 
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included (see Table 3 for results of the final model).  Firstly, age (centered at 45) contributed 
significantly, OR 0.97, 95% CI 0.94-0.99 which led to the addition of the age squared term in 
order to account for the curvilinear relationship between age and driving ability; the age squared 
term was also statistically significant (see Table 3).  Next, other drugs (narcotics, depressants, 
cannabinoids, and other drugs) were introduced, all of which significantly contributed to the 
model.  In addition, the interaction between stimulants and narcotics was also significant.  
Although this interaction might indicate a protective factor, whereby stimulant induced driving 
impairments are alleviated by narcotics, this finding should be interpreted with caution.  Only 11 
truck drivers tested positive for both stimulants and narcotics (5% of the stimulant group).  Also, 
the odds ratio for stimulant and narcotic positive drivers committing an UDA is not statistically 
significant, OR 0.34, 95% CI 0.14-1.94.  To complete the final model, previous driving record 
infractions all contributed (previous collisions, other convictions, speeding, and suspensions) 
with the exception of DWI convictions.  However, given the Chi-Square results demonstrating a 
higher number of DWI convictions among stimulant-positive drivers (see Table 1) as well the 
significant influence of alcohol on driving ability, this variable was left in the final regression 
model.  After all contributing variables were included, the resulting adjusted odds ratio 
demonstrates that drivers who committed an UDA had greater odds of being stimulant-positive 
than those who did not, OR 2.29, 95% CI 1.72-3.04. 
 The adjusted odds ratios for the top five most common UDAs (failure to keep in proper 
lane, driving too fast for conditions, operating vehicle in an erratic or reckless manner, making 
an improper turn, and failure to yield right of way or obey traffic signs), were all statistically 
significant with the exception of failure to yield right of way.  The odds of being stimulant 
positive were statistically significantly higher for drivers who failed to keep in the proper lane 
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(see Table 4).  Driving too fast for conditions was also statistically significant (see Table 5), as 
well as operating vehicle in an erratic or reckless manner (see Table 6).  The final top five UDA 
that attained significance was making an improper turn (see Table 7).  Lastly, the odds of being 
stimulant-positive for those who failed to yield right of way or obey traffic signs was not 
statistically significant (see Table 8).  
Discussion 
The hypothesis for the present study was supported: drivers who committed an UDA 
were at increased odds of being stimulant-positive, OR 2.29, 95% CI 1.72-3.04.  This is in the 
same direction as the findings by Drummer et al. (2004) in which truck drivers were statistically 
significantly more likely to be deemed culpable in a fatal collision, OR 8.83, 95% CI 1.00–78.  
The present study also demonstrated increased odds of being stimulant-positive in the event of 
specific UDAs (making an improper turn, failure to keep in proper lane, operating vehicle in an 
erratic or reckless manner, driving too fast for conditions, and failure to yield right of way or 
obey traffic signs).  This is consistent with driving simulator studies showing deleterious driving 
actions associated with stimulant use such as swerving, driving too fast or too slow, improper-
use of turning signal, and running red lights (for example, see Logan, 1996; Logan, Fligner, & 
Haddix, 1998; Silber et al., 2005).  The findings concerning specific UDAs must be interpreted 
while considering that there is a lack of exposure data.  The findings reveal that 0.58% (n = 429) 
of the entire sample of truck drivers (n = 73,178) tested positive for stimulants for all the years 
combined, and stimulant detection rates never exceeded one percent for each individual year.  
These results run contrary to the majority of studies in Australia and the United States that 
demonstrate rates of stimulant use between 10% and 91% (Brodie, Lyndal, & Elias, 2009; 
Crouch et al., 1993; Davey, Richards, & Freeman, 2007; Drummer et al., 2003; Drummer et al., 
2004; Mabbott & Hartley, 1999), and are more similar to the findings by Longo et al. (2000a) in 
THE INFLUENCE OF STIMULANTS ON TRUCK DRIVER 25                                                          
 
 
 
which 0.8% of a sample of Australian truck drivers tested positive for stimulants.  As previously 
discussed, all the above studies utilized samples of truck drivers who were killed as a result of 
the collision with the exception of Longo et al. (2000a).  In conjunction with the above studies, 
the results of the current study suggest that future research should consider populations of drivers 
who were not killed during a collision in order to determine alcohol and drug use.  Deceased 
populations might bias findings by inflating the rates of drug and alcohol detection.  
 Results of the Pearson’s Chi-square analyses support the inclusion of previous driving 
record and other drug-use as control variables, as these confounding variables were 
overrepresented among stimulant-positive drivers.  The addition of these variables marks an 
improvement over the limitations of previous culpability research in which potentially risky 
driving tendencies and other drug-use were not accounted for.   
 The use of UDAs as a proxy measure for culpability enabled the investigation of specific 
unsafe actions that are linked to stimulant use.  For stimulant-positive drivers in this sample, the 
odds of making an improper turn were highest (see Table 7).  Failure to keep in the proper lane 
followed with the second highest odds ratio (see Table 4).  It is interesting to note that these two 
UDAs were the biggest risk for stimulant-positive truck drivers.  Given the need to use one’s 
peripheral vision for turning a vehicle and for keeping between road lines (Summala, Nieminen, 
& Punto, 1996), these findings might support the possibility of a tunnel vision phenomenon.  
Both cognitive research (Mills et al., 2001) as well as driving-simulator studies (Silber et al., 
2005) suggest tunnel vision is a factor associated with stimulants-use, extended driving periods 
and sleep deprivation (Roge et al., 2003).  
 For the present study, the lack of information on stimulant blood concentration may 
create a biasing effect whereby the overall effect is underestimated.  Research demonstrates that 
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medium to high levels of stimulant blood concentrations are linked to culpability, and low levels 
are not, suggesting the impairing effects of stimulants might be restricted to higher levels 
(Drummer et al., 1994; Logan, Fligner, & Haddix, 1998; Terhune et al., 1992).  In addition, 
driving deficits are especially evident during the acute and withdrawal/rebound fatigue phase 
(Logan, 1996; Logan, 2002).  For the present study, the lack of information on stimulant blood 
concentration leads to the inclusion of drivers with low stimulant blood concentration levels. 
This could lead to an underestimation of the overall effect, as drivers with low levels of 
stimulants might not demonstrate driving impairments. Although this could imply an 
underestimation of the overall effect, this might add credence to the findings as removal of these 
drivers could increase the magnitude of the findings. 
Overall, the results of this study demonstrate the importance of ensuring that transport 
truck drivers do not use stimulants while driving. It is important to conduct drug screening in 
order to ensure drivers are not relying on stimulants as a fatigue countermeasure.  Employers 
and/or the government could conduct random drug screening on truck drivers.  This could 
potentially be conducted by Ministry of Transportation Officers at weigh stations, or perhaps in 
conjunction with transport truck company owners at their main location.    
Limitations 
 
 Although the inclusion of drivers who were not deceased as a result of the collision 
represents an improvement over previous research, use of the FARS database precludes the 
inclusion of collisions that did not involve a fatality.  This carries several implications.  Perhaps 
investigating officers implement a more vigorous means of investigation for fatal collisions.  
This could cause officers to more readily search for and assign UDAs to those involved in such a 
collision.  When observing the Chi-Square results in regards to UDAs (see Table 2), it seems as 
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if a large number of both stimulant-positive and stimulant-negative drivers committed UDAs.  
Although this does not change the findings that stimulant-positive drivers were at greater odds 
for committing an UDA, it might indicate investigating officers are readily and perhaps 
overzealously assigning UDAs when a fatality is involved.  In addition to missing data on 
collisions that did not involve a fatality, information on single vehicle collisions is also excluded.  
This could result in the exclusion of stimulant-positive drivers who crashed, but without the 
involvement of other vehicles.   
 Although the use of UDAs as a proxy measure of culpability allows for the investigation 
of specific driver actions, UDAs might not accurately reflect culpability.  An accepted technique 
for determining collision culpability is responsibility analysis (for example, see Drummer et al., 
2004, and Longo et al., 2000b).  Responsibility analysis is a culpability determining technique 
developed by Robertson and Drummer (1994) in which each driver is scored on the presence of 
any of the following factors: road conditions, vehicle conditions, driving conditions, collision 
type, witness observations, road law obedience, difficulty of task, and level of fatigue.  It is 
difficult to determine whether or not UDAs reflect culpability, or if culpability analysis itself is 
even preferable.  Although all of the culpability analysis variables are likely factors in 
culpability, this type of culpability assessment introduces the possibility of inaccuracy.  For 
example, witness observations can be inaccurate and are subject to bias.  Establishing task 
difficulty and level of fatigue requires subjective assessments and is therefore prone to error.  
Lastly, this type of responsibility analysis also fails to consider the role of other drivers in the 
crash.  Regardless, the present study did not use an established means of assigning culpability 
and instead relies on police records in which UDAs were recorded.  For this reason, culpability 
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might not be established.  Despite this, the results still demonstrate the negative influence of 
stimulants on driving.  
 There is no information on how drivers were or were not selected for drug testing within 
the FARS database.  It is possible that truck drivers who appeared intoxicated were selected for 
drug testing, thereby creating a biased sample.  That is, stimulant-positive drivers who did not 
appear intoxicated might not have been selected for drug testing, thereby leaving the more 
seriously impaired stimulant users for the current sample and artificially strengthening the 
results.  Research does indicate that police officers are adept at identifying drivers impaired by 
stimulants, and that increasing blood concentrations result in increased impairment ratings 
(Gustavsen, Morland, & Bramness, 2005).   
 Concerning research that demonstrates cognitive and driving simulator improvements 
linked to stimulant use, the current study precludes any cases in which stimulants might have 
caused driving improvements.  For example, only cases in which a collision occurred and 
resulted in a death are addressed in this study.  This focus on negative outcomes associated with 
stimulant use and driving prevents the investigation of the possibility of driving improvements 
associated with stimulant use. 
Future Directions 
The present study demonstrates the importance of accounting for previous driving record 
and other drugs as confounding variables.  Future research can strengthen the limited body of 
research by including information on blood concentration, and implementing culpability analysis 
as a means of determining culpability.  Further research is needed to investigate the influence of 
stimulants on transport truck drivers as well as regular drivers. 
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Future research should not investigate drug use and collision culpability exclusively 
among samples of deceased truck drivers.  The previously discussed tendency for biased results 
associated with deceased samples demonstrates the importance of including drivers who were 
not killed as a result of the collision.  In addition, information on specific driving actions 
influenced by stimulants and other drugs should be investigated.  Concerning stimulants and 
driving, researchers should investigate the possibility of a tunnel vision phenomenon. 
 The results also indicate relatively low rates of stimulant use among truck drivers.  This 
could be due to increased scrutiny for truck drivers via drug testing.  It might appear as if 
stimulants are not a significantly important area of concern among truck drivers.  However, it is 
possible that truck drivers are relying on more acceptable and/or less easily detected stimulants. 
Given the recent trends in “energy drinks” containing caffeine, taurine, and guarana, future 
research should investigate the influence of these stimulants on driving as well as their use 
among transport truck drivers.   
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Table 1 
Chi-square Results for Drug-use and Driving Records 
 
 
Stimulant-positive 
n (%) 
Stimulant-negative 
n (%) 
 
χ
2
 
 
p value 
 
 
Drugs 
 
    
     Narcotics 11 (5%) 79 (0.5%) 85.29 <.001 
 
     Depressants 8 (3.6%) 61 (0.4%) 58.00 <.001 
 
     Cannabinoids 22 (10%) 107 (0.6%) 254.66 <.001 
 
     Other Drugs 11 (5%) 226 (1.3%) 21.32 <.001 
 
Driving Record     
 
     Collisions 53 (24.1%) 2,900 (17.2%) 7.29 <.001 
 
     DWI Convictions 5 (2.3%) 126 (0.7%) 6.66 <.001 
 
     Other Convictions 94 (42.7%) 4,057 (24%) 41.37 <.001 
 
     Speeding 104 (47.3%) 5,114 (30.3%) 29.60 <.001 
 
     Suspensions 48 (21.8%) 1,229 (7.3%) 66.50 <.001 
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Table 2 
Chi-square Results for Any UDA and the Top Five UDAs 
 
 
Stimulant-positive 
n (%) 
Stimulant-negative 
n (%) 
 
χ
2
 
 
p value 
 
 
Any unsafe driving 
action (UDA) 
 
128 (58.2%) 
 
5999 (35.5%) 
 
48.54 
 
<.001 
 
Failure to keep in the 
proper lane 
 
 
65 (29.5%) 
 
2321 (13.7%) 
 
45.21 
 
<.001  
Driving too fast for 
conditions 
 
44 (20%) 1801 (10.7%) 19.68 <.001 
 
Operating vehicle in 
an erratic or reckless 
manner 
 
 
18 (8.2%) 
 
526 (3.1%) 
 
18.12 
 
<.001 
 
Making an improper 
turn 
 
16 (7.3%) 257 (1.5%) 45.75 <.001 
 
Failure to yield right 
of way or obey traffic 
signs 
 
13 (5.9%) 
 
 
1165 (6.9%) 
 
0.33 
 
0.565 
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Table 3 
Final Regression Model Predicting Any UDA for Stimulant-Positive Drivers 
 Adjusted Odds Ratio           95% CI p Value 
 
      
     Stimulants 
 
 
2.293 
 
          1.729 – 3.042 
 
<.001 
 
     Age*  0.993           0.966 – 1.020 .549 
 
     Age²** 1.073           1.052 – 1.094 <.001 
 
Other Drugs    
 
     Narcotics 2.306           1.449 – 3.670 <.001 
 
     Depressants 1.699           1.035 – 2.789 .036 
 
     Cannabinoid 1.496           1.048 – 2.135 .027 
 
     Other 1.491           1.147 – 1.937 .003 
 
     Stimulant x Narcotic 0.234           0.063 – 0.875 .031 
 
Prior Driving Record    
 
     Collisions 1.291           1.189 – 1.402 <.001 
 
     DWI Convictions 1.044           0.728 – 1.497 .816 
 
     Other Convictions 1.248           1.158 – 1.344 <.001 
 
     Speeding 1.135           1.059 – 1.217 <.001 
 
     Suspensions 1.182           1.406 – 1.336 .007 
 
*age was centered at 45 years 
**age squared to account for curvilinear relationship between age and driving performance 
 
 
 
 
 
THE INFLUENCE OF STIMULANTS ON TRUCK DRIVER 43                                                          
 
 
 
Table 4 
Final Regression Model Predicting Failure to Keep in Proper Lane for Stimulant-Positive 
Drivers 
 
 Adjusted Odds Ratio           95% CI p Value 
 
      
     Stimulants 
 
 
2.420 
 
          1.781 – 3.288 
 
<.001 
 
     Age*  1.035           0.998 – 1.074 .063 
 
     Age²** 1.057           1.030 – 1.084 <.001 
 
Other Drugs    
 
     Narcotics 2.485           1.518 – 4.067 <.001 
 
     Depressants 2.128           1.242 – 3.645 .006 
 
     Cannabinoid 1.211           0.771 – 1.903 .406 
 
     Other 1.979           1.466 – 2.671 <.001 
 
     Stimulant x Narcotic 0.177           0.034 – 0.928 .041 
 
Prior Driving Record    
 
     Collisions 1.252           1.122 – 1.397 <.001 
 
     DWI Convictions 0.998           0.616 – 1.618 .994 
 
     Other Convictions 1.262           1.142 – 1.394 <.001 
 
     Speeding 1.100           1.000 – 1.211 .051 
 
     Suspensions 1.114           0.946 – 1.310 .195 
 
*age was centered at 45 years 
**age squared to account for curvilinear relationship between age and driving performance 
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Table 5 
Final Regression Model Predicting Driving Too Fast for Conditions for Stimulant-Positive 
Drivers 
 Adjusted Odds Ratio           95% CI p Value 
 
      
     Stimulants 
 
 
2.073 
 
          1.470 – 3.924 
 
<.001 
 
     Age*  0.969           0.930 – 1.010 .142 
 
     Age²** 1.042           1.012 – 1.074 .006 
 
Other Drugs    
 
     Narcotics 2.189           1.236 – 3.876 .007 
 
     Depressants 0.705           0.313 – 1.587 .398 
 
     Cannabinoid 1.390           0.859 – 2.247 .180 
 
     Other 1.197           0.817 – 1.755 .356 
 
     Stimulant x       
     Narcotic*** 
 
-           - - 
 
Prior Driving Record    
 
     Collisions 1.197           1.059 – 1.353 .004 
 
     DWI Convictions 0.786           0.437 – 1.415 .422 
 
     Other Convictions 1.223           1.094 – 1.367 <.001 
 
     Speeding 1.050           0.943 – 1.168 .372 
 
     Suspensions 1.063           0.885 – 1.276 .512 
 
*age was centered at 45 years 
**age squared to account for curvilinear relationship between age and driving performance 
***no cases of stimulant and narcotic-positive drivers for this UDA 
 
 
 
THE INFLUENCE OF STIMULANTS ON TRUCK DRIVER 45                                                          
 
 
 
Table 6 
Final Regression Model Predicting Operating Vehicle in Erratic or Reckless Manner for 
Stimulant-Positive Drivers 
 
 Adjusted Odds Ratio           95% CI p Value 
 
      
     Stimulants 
 
 
2.320 
 
          1.364 – 3.943 
 
.002 
 
     Age*  0.965           0.893 – 1.042 
 
.358 
 
     Age²** 0.988           0.934 – 1.046 .684 
 
Other Drugs    
 
     Narcotics 2.182           0.851 – 5.597 .104 
 
     Depressants 0.945           0.280 – 3.195 .928 
 
     Cannabinoid 1.140           0.491 – 2.645 .761 
 
     Other 0.843           0.391 – 1.814 .661 
 
     Stimulant x Narcotic 1.287           0.200 – 8.284 .790 
 
Prior Driving Record    
 
     Collisions 0.814           0.640 – 1.035 .092 
 
     DWI Convictions 0.862           0.344 – 2.161 .752 
 
     Other Convictions 1.104           0.905 – 1.347 .330 
 
     Speeding 1.075           0.891 – 1.298 .448 
 
     Suspensions 1.606           1.212 – 2.128 <.001 
 
*age was centered at 45 years 
**age squared to account for curvilinear relationship between age and driving performance 
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Table 7 
Final Regression Model Predicting Making an Improper Turn for Stimulant-Positive Drivers 
 
 Adjusted Odds Ratio           95% CI p Value 
 
      
     Stimulants 
 
 
4.711 
 
          2.724 – 8.147 
 
<.001 
 
     Age*  0.925           0.835 – 1.026 .139 
 
     Age²** 1.058           0.984 – 1.137 .127 
 
Other Drugs    
 
     Narcotics 4.013           1.369 – 11.762 .011 
 
     Depressants 0.997           0.223 – 4.450 .997 
 
     Cannabinoid 1.219           0.432 – 3.435 .708 
 
     Other 0.403           0.097 – 1.669 .210 
 
     Stimulant x  
     Narcotic*** 
 
-           - - 
 
Prior Driving Record    
 
     Collisions 1.791           1.368 – 2.346 <.001 
 
     DWI Convictions 1.226           0.432 – 3.482 .702 
 
     Other Convictions 1.603           1.237 – 2.078 <.001 
 
     Speeding 0.847           0.648 – 1.108 .226 
 
     Suspensions 1.366           0.924 – 2.019 .117 
 
*age was centered at 45 years 
**age squared to account for curvilinear relationship between age and driving performance 
***no cases of stimulant and narcotic-positive drivers for this UDA 
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Table 8 
Final Regression Model Predicting Failure to Yield Right of Way or Obey Traffic Signs for 
Stimulant-Positive Drivers 
 
 Adjusted Odds Ratio           95% CI p Value 
 
      
     Stimulants 
 
 
0.877 
 
          0.495 – 1.554 
 
.653 
 
     Age*  0.953           0.908 – 1.000 .048 
 
     Age²** 1.115           1.079 – 1.152 <.001 
 
Other Drugs    
 
     Narcotics 0.864           0.311 – 2.406 .780 
 
     Depressants 0.424           0.102 – 1.761 .238 
 
     Cannabinoid 1.295           0.690 – 2.428 .421 
 
     Other 0.797           0.452 – 1.405 .433 
 
     Stimulant x        
     Narcotic*** 
 
-           - - 
 
Prior Driving Record    
 
     Collisions 1.266           1.092 – 1.467 .002 
 
     DWI Convictions 1.047           0.553 – 1.983 .888 
 
     Other Convictions 0.991           0.861 – 1.141 .898 
 
     Speeding 1.155           1.014 – 1.314 .030 
 
     Suspensions 1.149           0.923 – 1.431 .213 
 
*age was centered at 45 years 
**age squared to account for curvilinear relationship between age and driving performance 
***no cases of stimulant and narcotic-positive drivers for this UDA 
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Sample Flow-Chart With Inclusion and Exclusion Criteria 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flow chart of FARS cases selected for the present study with inclusion and exclusion 
criteria.   
N = 73,178 
-any truck (weight > 10,000 lbs.) 
-age > 20 years 
-blood tested for drugs 
 
n = 17,112 
-blood-alcohol concentration = 0 
n = 51,056 
-males only 
n = 52,282 
-truck tractor (cab only or with 
any number of trailing units; any 
weight) 
n = 220 
-stimulant positive drivers 
n = 16,982 
-stimulant negative drivers 
20,896 excluded 
-vehicles other than 
transport trucks 
33,941 excluded 
-blood-alcohol 
concentration > 0 
1,226 excluded 
-females 
3 excluded 
-unknown sex 
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Stimulant Use by Year for the entire sample (73,178) 
 
 
Figure 2. Percentage of total sample (N = 73,178) testing positive for stimulants based on 
analysis year (1993 through 2008).   
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